Дослідження містить перші національні репрезентативні дані про психічне здоров’я дорослих внутрішньо переміщених осіб (ВПО) в Україні. У дослідженні підкреслює...ься значний тягар психічних розладів, у тому числі посттравматичного стресового розладу (ПТСР), депресії та тривоги серед ВПО в Україні, особливо серед жінок. Крім того, значна кількість осіб має два або три розлади одночасно. Зафіксований високий рівень поширеності супутніх захворювань ПТСР, тривоги та депресії. Наші висновки підтверджують необхідність у розширеному, комплексному та травма – чутливому реагуванні в області охорони психічного здоров’я населення, що постраждало внаслідок конфлікту.
more
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an ...outcome. By engaging persons with disabilities in the process, we will also improve the outcomes for persons with disabilities.
The disability community has the slogan “Nothing about us without us,” reminding that we should include and work with persons with disabilities and their representative groups rather than plan or make decisions on their behalf. Persons with disabilities should be engaged throughout shelter programme planning, implementation, monitoring and evaluation.
more
The scale of West Africa’s Ebola epidemic has been attributed to the weak health systems of affected countries,
their lack of resources, the mobility of communities and their inexperience in dealing with Ebola. This briefing for African Affairs argues that these explanations lack important contex...t. The briefing examines responses to the outbreak and offers a different set of explanations, rooted in the history of the region and the political economy of global health and development. To move past technical discussions of “weak” health systems, it highlights how structural violence has contributed to the epidemic. As part of this, local people – their beliefs, concerns and priorities – have been marginalised. Both the crisis response and post-Ebola ‘reconstruction’ will be strengthened by acknowledgment of its long term structural underpinnings and from a more collaborative inclusion of local people.
more
A guide for effective aid
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...respective of interval between the doses was 63.1%, based on a median follow-up of 80 days, but tended to be higher when this interval was longer. The data reviewed at this time support the conclusion that the known and potential benefits of ChAdOx1-S/nCoV-19 [recombinant] vaccine outweigh the known and potential risks.
more
Throughout the region, heavy rains that intensified in late April have resulted in excessive flooding, affecting more than half a million people; damaging infrastructure and livelihoods and caused over 370 deaths. Although the rains have also brought relief to some areas that have been affected by t...he worst drought in decades, namely; parts of Ethiopia, Puntland, Somaliland and a number of countries in southern Africa, the food security situation in these areas is not expected to significantly improve, due to the scale and intensity of the El Nino-induced drought that has already depleted coping mechanisms.
more
Information about vaccine administration
ACAPS Briefing Note: Zika virus epidemic
Disaster Preparedness Training Programme
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
more
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic, Interim guidance 20 October 2020. This assessment tool covers the following aspects:
area distribution;
surface availability versus foreseen occupancy rate;
patient and staff flow...s;
ventilation requirement per specific areas;
visitors’ area and visitor flow; and
surge capacity.
more